Taro Pharmaceutical Industries Ltd reports results for the quarter ended in June - Earnings Summary

Taro Pharmaceutical Industries

28/07/2021 01:03

* Taro Pharmaceutical Industries Ltd  TARO.N  reported quarterly
adjusted earnings of $1.09​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for earnings
of 84 cents per share.
* Revenue rose 25.1% to $147.11 million from a year ago; 
analysts expected $137.23 million. 
* Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was a loss of 50 cents​.
* The mean earnings estimate of analysts had risen by about 3.7%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Taro Pharmaceutical Industries Ltd shares had fallen by 1.9%
this quarter and lost 3.8% so far this year.
* The company reported a quarterly loss of $18.77 million.
* Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $80.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated July 28 at 12:03 a.m.  ​All
figures in US dollars unless otherwise stated